Cargando…

Assessment of expenditure control and prescriptive appropriateness of biological drugs in autoimmune diseases and chronic inflammatory bowel disease

Detalles Bibliográficos
Autores principales: Capuozzo, Maurizio, Nava, Eduardo, Cascone, Stefania, Cinque, Claudia, Marra, Roberta, Ottaiano, Alessandro, Scognamiglio, Corinne, Palumbo, Emilia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3605548/
https://www.ncbi.nlm.nih.gov/pubmed/23526916
http://dx.doi.org/10.3389/fphar.2013.00031
_version_ 1782263909867061248
author Capuozzo, Maurizio
Nava, Eduardo
Cascone, Stefania
Cinque, Claudia
Marra, Roberta
Ottaiano, Alessandro
Scognamiglio, Corinne
Palumbo, Emilia
author_facet Capuozzo, Maurizio
Nava, Eduardo
Cascone, Stefania
Cinque, Claudia
Marra, Roberta
Ottaiano, Alessandro
Scognamiglio, Corinne
Palumbo, Emilia
author_sort Capuozzo, Maurizio
collection PubMed
description
format Online
Article
Text
id pubmed-3605548
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-36055482013-03-22 Assessment of expenditure control and prescriptive appropriateness of biological drugs in autoimmune diseases and chronic inflammatory bowel disease Capuozzo, Maurizio Nava, Eduardo Cascone, Stefania Cinque, Claudia Marra, Roberta Ottaiano, Alessandro Scognamiglio, Corinne Palumbo, Emilia Front Pharmacol Pharmacology Frontiers Media S.A. 2013-03-22 /pmc/articles/PMC3605548/ /pubmed/23526916 http://dx.doi.org/10.3389/fphar.2013.00031 Text en Copyright © 2013 Capuozzo, Nava, Cascone, Cinque, Marra, Ottaiano, Scognamiglio and Palumbo. http://creativecommons.org/licenses/by/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in other forums, provided the original authors and source are credited and subject to any copyright notices concerning any third-party graphics etc.
spellingShingle Pharmacology
Capuozzo, Maurizio
Nava, Eduardo
Cascone, Stefania
Cinque, Claudia
Marra, Roberta
Ottaiano, Alessandro
Scognamiglio, Corinne
Palumbo, Emilia
Assessment of expenditure control and prescriptive appropriateness of biological drugs in autoimmune diseases and chronic inflammatory bowel disease
title Assessment of expenditure control and prescriptive appropriateness of biological drugs in autoimmune diseases and chronic inflammatory bowel disease
title_full Assessment of expenditure control and prescriptive appropriateness of biological drugs in autoimmune diseases and chronic inflammatory bowel disease
title_fullStr Assessment of expenditure control and prescriptive appropriateness of biological drugs in autoimmune diseases and chronic inflammatory bowel disease
title_full_unstemmed Assessment of expenditure control and prescriptive appropriateness of biological drugs in autoimmune diseases and chronic inflammatory bowel disease
title_short Assessment of expenditure control and prescriptive appropriateness of biological drugs in autoimmune diseases and chronic inflammatory bowel disease
title_sort assessment of expenditure control and prescriptive appropriateness of biological drugs in autoimmune diseases and chronic inflammatory bowel disease
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3605548/
https://www.ncbi.nlm.nih.gov/pubmed/23526916
http://dx.doi.org/10.3389/fphar.2013.00031
work_keys_str_mv AT capuozzomaurizio assessmentofexpenditurecontrolandprescriptiveappropriatenessofbiologicaldrugsinautoimmunediseasesandchronicinflammatoryboweldisease
AT navaeduardo assessmentofexpenditurecontrolandprescriptiveappropriatenessofbiologicaldrugsinautoimmunediseasesandchronicinflammatoryboweldisease
AT casconestefania assessmentofexpenditurecontrolandprescriptiveappropriatenessofbiologicaldrugsinautoimmunediseasesandchronicinflammatoryboweldisease
AT cinqueclaudia assessmentofexpenditurecontrolandprescriptiveappropriatenessofbiologicaldrugsinautoimmunediseasesandchronicinflammatoryboweldisease
AT marraroberta assessmentofexpenditurecontrolandprescriptiveappropriatenessofbiologicaldrugsinautoimmunediseasesandchronicinflammatoryboweldisease
AT ottaianoalessandro assessmentofexpenditurecontrolandprescriptiveappropriatenessofbiologicaldrugsinautoimmunediseasesandchronicinflammatoryboweldisease
AT scognamigliocorinne assessmentofexpenditurecontrolandprescriptiveappropriatenessofbiologicaldrugsinautoimmunediseasesandchronicinflammatoryboweldisease
AT palumboemilia assessmentofexpenditurecontrolandprescriptiveappropriatenessofbiologicaldrugsinautoimmunediseasesandchronicinflammatoryboweldisease